Onward Medical N.V. (ONWD.BR)

EUR 4.01

(-0.25%)

Total Assets Summary of Onward Medical N.V.

Onward Medical N.V.'s latest annual total assets in 2023 was 43.62 Million EUR , down -43.04% from previous year.
Onward Medical N.V.'s latest quarterly total assets in 2024 Q2 was 46.85 Million EUR , down 0.0% from previous quarter.
Onward Medical N.V. reported annual total assets of 76.59 Million EUR in 2022, down -26.91% from previous year.
Onward Medical N.V. reported annual total assets of 104.79 Million EUR in 2021, up 638.52% from previous year.
Onward Medical N.V. reported quarterly total assets of 46.85 Million EUR for 2024 Q1, up 7.39% from previous quarter.
Onward Medical N.V. reported quarterly total assets of 43.62 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Onward Medical N.V. (2023 - 2017)

Historical Annual Total Assets of Onward Medical N.V. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	43.62 Million EUR	-43.04%
2022	76.59 Million EUR	-26.91%
2021	104.79 Million EUR	638.52%
2020	14.19 Million EUR	-39.22%
2019	23.34 Million EUR	144.19%
2018	9.56 Million EUR	16.83%
2017	8.18 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	46.85 Million EUR	0.0%
2024 Q1	46.85 Million EUR	7.39%
2023 Q4	43.62 Million EUR	0.0%
2023 Q1	59.02 Million EUR	-22.93%
2023 FY	43.62 Million EUR	-43.04%
2023 Q3	43.62 Million EUR	-26.09%
2023 Q2	59.02 Million EUR	0.0%
2022 Q3	76.59 Million EUR	-17.15%
2022 Q2	92.45 Million EUR	0.0%
2022 Q4	76.59 Million EUR	0.0%
2022 Q1	92.45 Million EUR	-11.78%
2022 FY	76.59 Million EUR	-26.91%
2021 Q4	104.79 Million EUR	0.0%
2021 FY	104.79 Million EUR	638.52%
2021 Q3	104.79 Million EUR	211.39%
2021 Q2	33.65 Million EUR	0.0%
2021 Q1	33.65 Million EUR	137.17%
2020 Q4	14.19 Million EUR	0.0%
2020 Q3	14.19 Million EUR	0.0%
2020 Q1	- EUR	0.0%
2020 FY	14.19 Million EUR	-39.22%
2019 FY	23.34 Million EUR	144.19%
2018 FY	9.56 Million EUR	16.83%
2017 FY	8.18 Million EUR	0.0%

Peer Total Assets Comparison of Onward Medical N.V.

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	17.65%
European Medical Solutions	43.75 Million EUR	0.295%
FERMENTALG	50.24 Million EUR	13.166%
argenx SE	4.11 Billion EUR	98.939%
BioSenic S.A.	9.55 Million EUR	-356.418%
Celyad Oncology SA	16.28 Million EUR	-167.958%
Hyloris Pharmaceuticals SA	47.68 Million EUR	8.498%
Oxurion NV	6.55 Million EUR	-566.092%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	14.965%
Financière de Tubize SA	1.92 Billion EUR	97.728%
UCB SA	15.53 Billion EUR	99.719%